The largest study of its kind to date found that 60% of Ehlers-Danlos syndrome patients achieved clinically significant pain reduction after 24 months of cannabis-based treatment, with many also reducing their opioid use.
Vaping is increasingly popular as a satisfying alternative to traditional smoking. A crucial factor in ensuring a pleasant vaping experience... read more
New research suggests the popular opioid painkiller offers minimal relief for chronic pain whilst significantly increasing the risk of heart... read more
In recent years, the cannabis industry in Canada has undergone a significant transformation as cannabis delivery services have come onto... read more
Removing cost barriers to medical cannabis enabled patients with chronic pain to significantly reduce their reliance on prescription opioids, with... read more
When medical cannabis was legalised in the UK in 2018, it was done so without care. The tragic case of... read more
Medical cannabis is once again under attack, as headlines scream that the treatment does “more harm than good”. But the... read more
“I think the best way for me to say it is it’s just sink or swim,” he says. “You either... read more
The Medical Cannabis Clinicians Society has published a comprehensive 189-page guide providing evidence-based medical cannabis oil dosing protocols for 12... read more
What makes good cannabis good? It’s an ongoing conversation within the cannabis industry, particularly among those professionals with a genuine... read more
Since medical cannabis was legalised in the UK in November 2018, an estimated 80,000 patients have... read more
